Conventional and alternative allergen immunotherapy: do they work? are they safe?
- 1 May 1994
- journal article
- review article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 24 (5) , 416-422
- https://doi.org/10.1111/j.1365-2222.1994.tb00929.x
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- T cells and eosinophils in the pathogenesis of asthmaImmunology Today, 1992
- Controlled trial of hyposensitisation in children with food-induced hyperkinetic syndromeThe Lancet, 1992
- A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclassesJournal of Allergy and Clinical Immunology, 1990
- Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitisJournal of Allergy and Clinical Immunology, 1990
- Immunotherapy with a standardized Dermatophagoides pteronyssinus extractJournal of Allergy and Clinical Immunology, 1990
- Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extractJournal of Allergy and Clinical Immunology, 1990
- A double‐blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (Conjuvac®) in patients with perennial rhinitisAllergy, 1989
- Does the effect of immunotherapy last after termination of treatment?Allergy, 1988
- Immunotherapy with cat- and dog-dander extracts II. In vivo and in vitro immunologic effects observed in a 1-year double-blind placebo studyJournal of Allergy and Clinical Immunology, 1986
- VACCINATION AGAINST HAY FEVER: REPORT OF RESULTS DURING THE LAST THREE YEARS.The Lancet, 1914